Werewolf Therapeutics, Inc. (HOWL): Price and Financial Metrics
HOWL Price/Volume Stats
Current price | $1.45 | 52-week high | $8.19 |
Prev. close | $1.49 | 52-week low | $1.26 |
Day low | $1.42 | Volume | 181,700 |
Day high | $1.57 | Avg. volume | 280,213 |
50-day MA | $1.51 | Dividend yield | N/A |
200-day MA | $2.46 | Market Cap | 64.62M |
HOWL Stock Price Chart Interactive Chart >
Werewolf Therapeutics, Inc. (HOWL) Company Bio
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It offers PREDATOR, a platform of protein engineering technology to design and engineer the future of immuno-oncology biotherapeutics for patients. The company's lead product candidates include WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. It also develops WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
HOWL Price Returns
1-mo | N/A |
3-mo | -18.54% |
6-mo | -39.33% |
1-year | -78.55% |
3-year | -79.08% |
5-year | N/A |
YTD | -2.03% |
2024 | -61.66% |
2023 | 88.29% |
2022 | -82.79% |
2021 | N/A |
2020 | N/A |
Loading social stream, please wait...